Lynn A. Tetrault - May 9, 2025 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role
Director
Signature
/s/ Ali Olivo, Attorney-in-Fact
Stock symbol
NEO
Transactions as of
May 9, 2025
Transactions value $
$56,974
Form type
4
Date filed
5/9/2025, 05:26 PM
Previous filing
Sep 11, 2024
Next filing
May 23, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
TETRAULT LYNN A. Director 9490 NEOGENOMICS WAY, FORT MYERS /s/ Ali Olivo, Attorney-in-Fact 2025-05-13 0001645512

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEO Common Stock Purchase $57K +7K $8.14 7K May 9, 2025 Lynn Tetrault Rollover IRA
holding NEO Common Stock 61.4K May 9, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NEO Stock Option (Right to Buy) 2.14K May 9, 2025 Common Stock 2.14K $22.52 Direct
holding NEO Stock Option (Right to Buy) 3.45K May 9, 2025 Common Stock 3.45K $28.54 Direct
holding NEO Stock Option (Right to Buy) 3.71K May 9, 2025 Common Stock 3.71K $40.90 Direct
holding NEO Stock Option (Right to Buy) 972 May 9, 2025 Common Stock 972 $41.76 Direct
holding NEO Stock Option (Right to Buy) 13.9K May 9, 2025 Common Stock 13.9K $8.10 Direct
holding NEO Stock Option (Right to Buy) 8.35K May 9, 2025 Common Stock 8.35K $14.82 Direct
holding NEO Stock Option (Right to Buy) 8.67K May 9, 2025 Common Stock 8.67K $13.71 Direct
holding NEO Restricted Stock Unit 12.3K May 9, 2025 Common Stock 12.3K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Once vested, the shares of common stock are not subject to expiration.